论文部分内容阅读
目的探究1%阿托品眼液治疗青少年早期近视的临床疗效。方法对我院2014年3月到2015年12月间接收的80例青少年早期近视患者进行治疗,按照随机序号法将患者分为对照组和观察组,对照组采用常规方法治疗,观察组采用1%阿托品眼液治疗,观察两组效果并进行比较。结果两组患者在治疗前视力无明显变化,治疗后观察组视力明显好于对照组,两组比较存在明显差异,P<0.05,差异具有统计学意义。两组患者的不良反应发生率均为5%,两组不良反应组间比较无明显差异,且没有对患者产生严重影响。结论 1%阿托品眼液治疗青少年早期近视的临床疗效良好,可以有效改善早期近视患者的视力,同时无严重不良反应,因而值得我们在临床中借鉴使用。
Objective To investigate the clinical efficacy of 1% atropine eye drops in the treatment of early myopia in adolescents. Methods 80 cases of young patients with early myopia received from March 2014 to December 2015 in our hospital were treated. According to the random number method, the patients were divided into control group and observation group. The control group was treated by conventional method. The observation group was treated with 1 % Atropine eye drops treatment, the two groups were observed and compared. Results There was no significant change in visual acuity between the two groups before treatment. After treatment, the visual acuity of the observation group was significantly better than that of the control group. There was significant difference between the two groups (P <0.05). The difference was statistically significant. The incidence of adverse reactions in both groups were 5%, there was no significant difference between the two groups of adverse reactions, and did not have serious impact on patients. Conclusion 1% atropine eye drops treatment of early myopia in young patients with good clinical efficacy, can effectively improve the early vision of patients with visual acuity, without serious adverse reactions, which deserves our reference in the clinical use.